Cargando…

Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action

Type 2 diabetes is characterized by impaired insulin secretion from pancreatic β‐cells and/or reduced response of target tissues to insulin. Good glycemic control delays the development and slows the progression of micro‐ and macrovascular complications. Although there are numerous glucose‐lowering...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Yoshihito, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020327/
https://www.ncbi.nlm.nih.gov/pubmed/24843771
http://dx.doi.org/10.1111/jdi.12214